286 related articles for article (PubMed ID: 32253240)
41. Intravenous infusion of donor apoptotic leukocytes before transplantation delays allogeneic islet graft rejection through regulatory T cells.
Mougel F; Bonnefoy F; Kury-Paulin S; Borot S; Perruche S; Kantelip B; Penfornis A; Saas P; Kleinclauss F
Diabetes Metab; 2012 Dec; 38(6):531-7. PubMed ID: 23182461
[TBL] [Abstract][Full Text] [Related]
42. A potential immunosuppressive effect of anti-lymphocyte function-associated antigen-1 monoclonal antibody on islet transplantation.
Gotoh M; Fukuzaki T; Monden M; Dono K; Kanai T; Yagita H; Okumura K; Mori T
Transplantation; 1994 Jan; 57(1):123-6. PubMed ID: 7904780
[TBL] [Abstract][Full Text] [Related]
43. Single-cell transcriptomics reveal that PD-1 mediates immune tolerance by regulating proliferation of regulatory T cells.
Leung CS; Yang KY; Li X; Chan VW; Ku M; Waldmann H; Hori S; Tsang JCH; Lo YMD; Lui KO
Genome Med; 2018 Sep; 10(1):71. PubMed ID: 30236153
[TBL] [Abstract][Full Text] [Related]
44. Blockade of LIGHT/HVEM and B7/CD28 signaling facilitates long-term islet graft survival with development of allospecific tolerance.
Fan K; Wang H; Wei H; Zhou Q; Kou G; Hou S; Qian W; Dai J; Li B; Zhang Y; Zhu T; Guo Y
Transplantation; 2007 Sep; 84(6):746-54. PubMed ID: 17893608
[TBL] [Abstract][Full Text] [Related]
45. Ex vivo expansion of CD4+CD25+FoxP3+ T regulatory cells based on synergy between IL-2 and 4-1BB signaling.
Elpek KG; Yolcu ES; Franke DD; Lacelle C; Schabowsky RH; Shirwan H
J Immunol; 2007 Dec; 179(11):7295-304. PubMed ID: 18025172
[TBL] [Abstract][Full Text] [Related]
46. A novel prevascularized tissue-engineered chamber as a site for allogeneic and xenogeneic islet transplantation to establish a bioartificial pancreas.
Liu Y; Yang M; Cui Y; Yao Y; Liao M; Yuan H; Gong G; Deng S; Zhao G
PLoS One; 2020; 15(12):e0234670. PubMed ID: 33270650
[TBL] [Abstract][Full Text] [Related]
47. Engineering Pancreatic Islets to Transiently Codisplay on Their Surface Thrombomodulin and CD47 Immunomodulatory Proteins as a Means of Mitigating Instant Blood-Mediated Inflammatory Reaction following Intraportal Transplantation.
Turan A; Tarique M; Zhang L; Kazmi S; Ulker V; Tedla MG; Badal D; Yolcu ES; Shirwan H
J Immunol; 2024 Jun; 212(12):1971-1980. PubMed ID: 38709159
[TBL] [Abstract][Full Text] [Related]
48. Posttransplantation systemic immunomodulation with SA-FasL-engineered donor splenocytes has robust efficacy in preventing cardiac allograft rejection in mice.
Zhao H; Woodward KB; Shirwan H; Grimany-Nuno O; Yolcu ES
Transplant Proc; 2013 Jun; 45(5):1805-7. PubMed ID: 23769048
[TBL] [Abstract][Full Text] [Related]
49. Transplantation of co-aggregates of Sertoli cells and islet cells into liver without immunosuppression.
Takemoto N; Liu X; Takii K; Teramura Y; Iwata H
Transplantation; 2014 Feb; 97(3):287-93. PubMed ID: 24342973
[TBL] [Abstract][Full Text] [Related]
50. Rapamycin and interleukin-10 treatment induces T regulatory type 1 cells that mediate antigen-specific transplantation tolerance.
Battaglia M; Stabilini A; Draghici E; Gregori S; Mocchetti C; Bonifacio E; Roncarolo MG
Diabetes; 2006 Jan; 55(1):40-9. PubMed ID: 16380475
[TBL] [Abstract][Full Text] [Related]
51. Low-dose IL-2 prevents murine chronic cardiac allograft rejection: Role for IL-2-induced T regulatory cells and exosomes with PD-L1 and CD73.
Ravichandran R; Itabashi Y; Fleming T; Bansal S; Bowen S; Poulson C; Bharat A; Bremner R; Smith M; Mohanakumar T
Am J Transplant; 2022 Sep; 22(9):2180-2194. PubMed ID: 35603986
[TBL] [Abstract][Full Text] [Related]
52. Combination therapy of an iNKT cell ligand and CD40-CD154 blockade establishes islet allograft acceptance in nonmyeloablative bone marrow transplant recipients.
Kanzawa T; Hirai T; Fukuda H; Katsumata H; Ishii R; Ikemiyagi M; Ishii Y; Saiga K; Okumi M; Tanabe K
Acta Diabetol; 2019 May; 56(5):541-550. PubMed ID: 30758788
[TBL] [Abstract][Full Text] [Related]
53. Local expression of B7-H4 by recombinant adenovirus transduction in mouse islets prolongs allograft survival.
Wang X; Hao J; Metzger DL; Mui A; Ao Z; Verchere CB; Chen L; Ou D; Warnock GL
Transplantation; 2009 Feb; 87(4):482-90. PubMed ID: 19307783
[TBL] [Abstract][Full Text] [Related]
54. Improving allogeneic islet transplantation by suppressing Th17 and enhancing Treg with histone deacetylase inhibitors.
Sugimoto K; Itoh T; Takita M; Shimoda M; Chujo D; SoRelle JA; Naziruddin B; Levy MF; Shimada M; Matsumoto S
Transpl Int; 2014 Apr; 27(4):408-15. PubMed ID: 24410777
[TBL] [Abstract][Full Text] [Related]
55. Roles of Toll-like receptors in allogeneic islet transplantation.
Ro H; Hong J; Kim BS; Lee EW; Kim MG; Han KH; Yeom HJ; Lee EM; Jeong JC; Oh KH; Ahn C; Yang J
Transplantation; 2012 Nov; 94(10):1005-12. PubMed ID: 23169223
[TBL] [Abstract][Full Text] [Related]
56. CCL22 Prevents Rejection of Mouse Islet Allografts and Induces Donor-Specific Tolerance.
Montane J; Obach M; Alvarez S; Bischoff L; Dai DL; Soukhatcheva G; Priatel JJ; Hardenberg G; Levings MK; Tan R; Orban PC; Verchere CB
Cell Transplant; 2015; 24(10):2143-54. PubMed ID: 26423995
[TBL] [Abstract][Full Text] [Related]
57. A combination regimen of low-dose bortezomib and rapamycin prolonged the graft survival in a murine allogeneic islet transplantation model.
Hong SH; Kim K; Shin JS; Chung H; Park CG
Immunol Lett; 2019 Dec; 216():21-27. PubMed ID: 31593743
[TBL] [Abstract][Full Text] [Related]
58. Transient depletion of dividing T lymphocytes in mice induces the emergence of regulatory T cells and dominant tolerance to islet allografts.
Giraud S; Barrou B; Sebillaud S; Debré P; Klatzmann D; Thomas-Vaslin V
Am J Transplant; 2008 May; 8(5):942-53. PubMed ID: 18341686
[TBL] [Abstract][Full Text] [Related]
59. Regulatory T cells maintain peripheral tolerance to islet allografts induced by intrathymic injection of MHC class I allopeptides.
Saborio DV; Chowdhury NC; Jin MX; Chandraker A; Sayegh MH; Oluwole SF
Cell Transplant; 1999; 8(4):375-81. PubMed ID: 10478717
[TBL] [Abstract][Full Text] [Related]
60. A hydrogel platform for co-delivery of immunomodulatory proteins for pancreatic islet allografts.
Medina JD; Barber GF; Coronel MM; Hunckler MD; Linderman SW; Quizon MJ; Ulker V; Yolcu ES; Shirwan H; García AJ
J Biomed Mater Res A; 2022 Nov; 110(11):1728-1737. PubMed ID: 35841329
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
